Ekers 2017.

Trial name or title	Community pHarmaciEs Mood Intervention STudy (CHEMIST)
Methods	Design: pilot RT Groups: intervention group (enhanced support for depression); control group (usual care)
Participants	Pharmacies: 7 Pharmacy users: 130 ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ Pharmacy users: patients with sub‐threshold depression Setting: unclear Country: UK
Interventions	Pharmacy worker‐directed intervention: none specific but pharmacists must have experience of extended role or training to Royal Society of Public Health standard (Understanding Health Improvement Level 2). ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ Pharmacy user‐directed intervention: behavioural activation focused self‐help support; proactive follow‐up; symptom monitoring; and decision supported signposting Delivered by: pharmacists Type: condition management Mode of delivery: face‐to‐face Duration: 4 to 6 sessions over 4 months Pharmacy user control: usual care
Outcomes	Pharmacy worker: not targeted ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ Pharmacy user: Clinical: not assessed Psychological health: depression, anxiety Behavioural: participants use of intervention Quality of life: SF‐12, EQ‐5D Process: qualitative interviews Costs: AD‐SUS (Adult Service Use Schedule)
Starting date	13 June 2016
Contact information	liz.littlewood@york.ac.uk; david.ekers@york.ac.uk
Notes	Funding NIHR